Catalyst Event
BioNTech SE (BNTX) · Other
From KEDI U.S. Medical AI Index (KUSMAI)
3/24/2026, 12:00:00 AM
Announced on March 24, 2026, the presentation of positive clinical data for its late-stage lung cancer portfolio at the European Lung Cancer Congress (ELCC) from March 25-28, 2026; medium impact from clinical results expected.
Korean Translation
2026년 3월 24일, 3월 25일부터 28일까지 열리는 유럽폐암학회(ELCC)에서 임상 데이터 발표 예정됨. 임상 결과 발표에 따른 중간 수준의 영향이 예상됨.
Related Recent Events
NVIDIA Corporation (NVDA) · Earnings Release
NVIDIA's Q1 2027 earnings release is scheduled for May 20, 2026; Medium importance is assigned as earnings typically drive 5-10% volatility, and analysts forecast an EPS of $1.74-$1.76 estimated.
5/20/2026, 12:00:00 AM
Schrodinger Inc (SDGR) · Earnings Release
First quarter 2026 earnings release scheduled. Analysts forecast an EPS of approximately -$0.56. As a major price catalyst, high importance is expected.
5/6/2026, 12:00:00 AM
Tempus AI Inc (TEM) · Earnings Release
Tempus AI is expected to report its Q1 2026 earnings, with analysts forecasting revenue of approximately $345.40M and a normalized EPS of -$0.19; medium impact expected from quarterly earnings release, scheduled.
5/5/2026, 12:00:00 AM
Hims & Hers Health Inc (HIMS) · Earnings Release
Q1 2026 earnings release and conference call, with low importance estimated due to the routine nature of the announcement, scheduled.
5/5/2026, 12:00:00 AM
Alphabet Inc (GOOGL) · Earnings Release
Alphabet's Q1 2026 earnings release is scheduled; major tech earnings typically cause >=5% price impact, justifying a Medium importance estimate.
4/23/2026, 12:00:00 AM
Intuitive Surgical Inc (ISRG) · Earnings Release
Intuitive Surgical's first-quarter 2026 earnings release is scheduled. I estimate Medium importance as earnings reports typically cause significant price movement, so the event is scheduled.
4/21/2026, 12:00:00 AM